Progressive Safe Travels
Natural health product licensed in Canada
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80080333
- Status
- Active licence
- Licence date
- 29 September 2017
- Revision date
- 8 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium breve Source : HA-129 | 3.3 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 3.3 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 1.35 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : HA-122 | 1.35 Milliards d'UFC | Not calculated |
| Saccharomyces boulardii Source : En entier | 5 Milliards d'UFC | Not calculated |
| Saccharomyces boulardii Source : En entier | 250 milligramme | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 0.81 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : HA-132 | 0.81 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : HA-135 | 0.3 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 0.3 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : HA-116 | 0.09 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Cellule entière | 0.09 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : HA-111 | 8.925 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 8.925 Milliards d'UFC | Not calculated |
| Ligilactobacillus salivarius Source : Cellule entière | 0.075 Milliards d'UFC | Not calculated |
| Ligilactobacillus salivarius Source : HA-118 | 0.075 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 0.15 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : HA-114 | 0.15 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Acide ascorbique, Fécule de pomme de terre, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides intestinal comfort for travellers. Helps to reduce the risk of traveller's diarrhea. Helps to reduce the risk of antibiotic-associated diarrhea. Source of probiotics. Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment). Do not use if you are experiencing nausea, fever, vomiting, blood diarrhoea or severe abdominal pain. This product has come into contact with milk and soy. Do not use if you have a milk or soy allergy.
- Précautions et mises en garde
Discontinue use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhoea) occur, worsen, or persist beyond 3 days.
Source
Official Health Canada record, licence 80080333
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.